phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000576.v1.p1 Angelman Syndrome Natural History Protocol | Version 1: passed embargo
| VDAS | 245 | Case Set | | |
phs000578.v1.p1 Nondystrophic Myotonias | Version 1: passed embargo
| VDAS | 95 | Longitudinal | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000017.v3.p1 Whole Genome Association Study of Bipolar Disorder | Versions 1-3: passed embargo
| VDAS | 3261 | Case-Control | Links | AFFY_6.0
|
phs000521.v1.p1 Episodic Ataxia Syndrome | Version 1: passed embargo
| VDAS | 131 | Longitudinal | | |
phs001289.v1.p1 Characteristics of Andersen-Tawil Syndrome | Version 1: passed embargo
| VDAS | 29 | Longitudinal | Links | |
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs001584.v1.p1 eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants | Version 1: passed embargo
| VDAS | 83717 | Case-Control | | Nimblegen Custom SeqCap
|
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes | Version 1: passed embargo
| VDAS | 55029 | Case-Control, Cohort | Links | 1000 Genomes
|
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000718.v1.p1 Trisomy 21 Nondisjunction (T21NDJ) | Version 1: passed embargo
| VDAS | 2230 | Parent-Offspring Trios, Case Set | Links | HumanOmniExpressExome BeadChip
|
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000742.v1.p1 The Epilepsy Phenome/Genome Project | Version 1: passed embargo
| VDAS | 5538 | Parent-Offspring Trios, Parent-Offspring | Links | |